Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2015111325025N1Phase 3Completed
Phase 3, single-blind trial of propofol, ketamine, thiopental and fentanyl in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Sedation efficacy. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2015111325025N1.